BCL9L antibody (AA 525-575)
-
- Target See all BCL9L Antibodies
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
Binding Specificity
- AA 525-575
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BCL9L antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunoprecipitation (IP)
- Purpose
- Rabbit anti-BCL9L Antibody, Affinity Purified
- Purification
- Affinity Purified
- Immunogen
- between AA 525 and 575
- Isotype
- IgG
- Top Product
- Discover our top product BCL9L Primary Antibody
-
-
- Application Notes
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
- Restrictions
- For Research Use only
-
- Concentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C
- Expiry Date
- 12 months
-
- Target
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
- Alternative Name
- BCL9L (BCL9L Products)
- Synonyms
- BCL9-2 antibody, DLNB11 antibody, B9L antibody, BC003321 antibody, bcl9-2 antibody, BCL9L antibody, B-cell CLL/lymphoma 9 like antibody, B cell CLL/lymphoma 9-like antibody, B-cell CLL/lymphoma 9-like antibody, BCL9L antibody, Bcl9l antibody, bcl9l antibody
- Background
- Background: B-cell lymphoma 9-like protein (BCL9L) is a transcriptional regulator that acts as an activator. BCL9L promotes beta-catenin transcriptional activity and plays a role in tumorigenesis [taken from the Universal Protein Resource (UniProt) Q86UU0].
- Gene ID
- 283149
- NCBI Accession
- NP_872363
- UniProt
- Q86UU0
- Pathways
- Stem Cell Maintenance
-